145 related articles for article (PubMed ID: 23345977)
1. Higher lung accumulation of intravenously injected organic nanotubes.
Maitani Y; Nakamura Y; Kon M; Sanada E; Sumiyoshi K; Fujine N; Asakawa M; Kogiso M; Shimizu T
Int J Nanomedicine; 2013; 8():315-23. PubMed ID: 23345977
[TBL] [Abstract][Full Text] [Related]
2. Organic nanotubes for drug loading and cellular delivery.
Wakasugi A; Asakawa M; Kogiso M; Shimizu T; Sato M; Maitani Y
Int J Pharm; 2011 Jul; 413(1-2):271-8. PubMed ID: 21540092
[TBL] [Abstract][Full Text] [Related]
3. Effects of PEGylation on the physicochemical properties and in vivo distribution of organic nanotubes.
Ding W; Minamikawa H; Kameta N; Shimizu T; Masuda M
Int J Nanomedicine; 2014; 9():5811-23. PubMed ID: 25540582
[TBL] [Abstract][Full Text] [Related]
4. Molecular-Level Understanding of the Encapsulation and Dissolution of Poorly Water-Soluble Ibuprofen by Functionalized Organic Nanotubes Using Solid-State NMR Spectroscopy.
Liu N; Higashi K; Kikuchi J; Ando S; Kameta N; Ding W; Masuda M; Shimizu T; Ueda K; Yamamoto K; Moribe K
J Phys Chem B; 2016 May; 120(19):4496-507. PubMed ID: 27123961
[TBL] [Abstract][Full Text] [Related]
5. Diffusion Behavior of Differently Charged Molecules in Self-Assembled Organic Nanotubes Studied Using Imaging Fluorescence Correlation Spectroscopy.
Ghimire G; Espinoza R; Xu H; Nagasaka S; Kameta N; Masuda M; Higgins DA; Ito T
Langmuir; 2019 Jun; 35(24):7783-7790. PubMed ID: 31125237
[TBL] [Abstract][Full Text] [Related]
6. Encapsulation of poorly water-soluble drugs into organic nanotubes for improving drug dissolution.
Moribe K; Makishima T; Higashi K; Liu N; Limwikrant W; Ding W; Masuda M; Shimizu T; Yamamoto K
Int J Pharm; 2014 Jul; 469(1):190-6. PubMed ID: 24746412
[TBL] [Abstract][Full Text] [Related]
7. Functionalized organic nanotubes as tubular nonviral gene transfer vector.
Ding W; Wada M; Kameta N; Minamikawa H; Shimizu T; Masuda M
J Control Release; 2011 Nov; 156(1):70-5. PubMed ID: 21777631
[TBL] [Abstract][Full Text] [Related]
8. Size and shape effects in the biodistribution of intravascularly injected particles.
Decuzzi P; Godin B; Tanaka T; Lee SY; Chiappini C; Liu X; Ferrari M
J Control Release; 2010 Feb; 141(3):320-7. PubMed ID: 19874859
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary targeting microparticulate camptothecin delivery system: anticancer evaluation in a rat orthotopic lung cancer model.
Chao P; Deshmukh M; Kutscher HL; Gao D; Rajan SS; Hu P; Laskin DL; Stein S; Sinko PJ
Anticancer Drugs; 2010 Jan; 21(1):65-76. PubMed ID: 19966540
[TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
Yang L; Cui F; Cun D; Tao A; Shi K; Lin W
Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779
[TBL] [Abstract][Full Text] [Related]
11. Development and pharmacological evaluation of a PEG based nanoparticulate camptothecin analog for oral administration.
Nekkanti V; Venkateswarlu V; Ansari KA; Pillai R
Curr Drug Deliv; 2011 Nov; 8(6):661-6. PubMed ID: 22313161
[TBL] [Abstract][Full Text] [Related]
12. Development of Dendrimer Encapsulated Radio-Ytterbium and Biodistributionin Tumor Bearing Mice.
Aghaei-Amirkhizi N; Moghaddam-Banaem L; Athari-Allaf M; Sadjadi S; Johari-Daha F
IEEE Trans Nanobioscience; 2016 Sep; 15(6):549-554. PubMed ID: 27824577
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy compared between irinotecan-loaded microspheres HepaSphere and DC bead in a model of VX2 liver metastases in the rabbit.
Namur J; Pascale F; Maeda N; Sterba M; Ghegediban SH; Verret V; Paci A; Seck A; Osuga K; Wassef M; Reb P; Laurent A
J Vasc Interv Radiol; 2015 Jul; 26(7):1067-1075.e3. PubMed ID: 25952641
[TBL] [Abstract][Full Text] [Related]
14. Hydroxycamptothecin Nanorods Prepared by Fluorescently Labeled Oligoethylene Glycols (OEG) Codendrimer: Antitumor Efficacy in Vitro and in Vivo.
Guo Y; Zhao Y; Wang T; Li R; Han M; Dong Z; Zhu C; Wang X
Bioconjug Chem; 2017 Feb; 28(2):390-399. PubMed ID: 27982573
[TBL] [Abstract][Full Text] [Related]
15. Fate of GdF
Mahaling B; Verma M; Mishra G; Chaudhuri S; Dutta D; Sivakumar S
Nanotoxicology; 2020 Jun; 14(5):577-594. PubMed ID: 31928284
[TBL] [Abstract][Full Text] [Related]
16. Shape-Dependent Biodistribution of Biocompatible Silk Microcapsules.
Cao S; Tang R; Sudlow G; Wang Z; Liu KK; Luan J; Tadepalli S; Seth A; Achilefu S; Singamaneni S
ACS Appl Mater Interfaces; 2019 Feb; 11(5):5499-5508. PubMed ID: 30640448
[TBL] [Abstract][Full Text] [Related]
17. Preparation of pegylated nano-liposomal formulation containing SN-38: In vitro characterization and in vivo biodistribution in mice.
Atyabi F; Farkhondehfai A; Esmaeili F; Dinarvand R
Acta Pharm; 2009 Jun; 59(2):133-44. PubMed ID: 19564139
[TBL] [Abstract][Full Text] [Related]
18. In vivo biodistribution and biological impact of injected carbon nanotubes using magnetic resonance techniques.
Al Faraj A; Fauvelle F; Luciani N; Lacroix G; Levy M; Crémillieux Y; Canet-Soulas E
Int J Nanomedicine; 2011; 6():351-61. PubMed ID: 21499425
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice.
Schluep T; Cheng J; Khin KT; Davis ME
Cancer Chemother Pharmacol; 2006 May; 57(5):654-62. PubMed ID: 16133526
[TBL] [Abstract][Full Text] [Related]
20. Fabrication and evaluation of nanoparticle-assembled BSA microparticles for enhanced liver delivery of glycyrrhetinic acid.
Wang W; Lei Y; Sui H; Zhang W; Zhu R; Feng J; Wang H
Artif Cells Nanomed Biotechnol; 2017 Jun; 45(4):740-747. PubMed ID: 27267996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
